Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 29 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (24)
P 2 (1)

Trial Status

Completed9
Unknown9
Not Yet Recruiting6
Suspended2
Active Not Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT06375967Not ApplicableSuspendedPrimary

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

NCT07559968Not ApplicableNot Yet Recruiting

12-mm Partial Covered Versus Bare Self-Expandable Metallic Stents for Malignant Distal Biliary Obstruction

NCT06653192Not ApplicableSuspendedPrimary

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

NCT07558304Not ApplicableNot Yet Recruiting

Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)

NCT05169398Not ApplicableRecruitingPrimary

EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent

NCT04406961Not ApplicableCompleted

Endoscopic Antegrade Sphincterotomy (ASD) Versus Standard Sphincterotomy

NCT06666699Not ApplicableWithdrawnPrimary

RIVOS Feasibility (MBO)

NCT07115420Not ApplicableNot Yet RecruitingPrimary

Improving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically Placed Internal Stents to Prevent Blockage of a Lumen Apposing Metal Stent

NCT03672019Active Not RecruitingPrimary

A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage

NCT04898777Not ApplicableCompletedPrimary

EUS-Guided Choledochoduodenostomy Versus ERCP for Primary Biliary Decompression in Distal Malignant Biliary Obstruction

NCT06550973Not ApplicableNot Yet RecruitingPrimary

PROceeding With Advanced Techniques in Case of Distal Malignant Biliary Obstruction and Difficult Biliary Cannulation comparEd With Therapeutic-EUS: the PROMETHEUS Trial

NCT06552208CompletedPrimary

Biliary Obstruction of Neoplastic Origin Treated With Drainage. A Prognostic Study.

NCT05786326Not ApplicableCompletedPrimary

Multihole Fully Covered Metallic Stents in the Management of Malignant Biliary Obstruction

NCT06375954Not ApplicableNot Yet RecruitingPrimary

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

NCT06375928Not ApplicableNot Yet RecruitingPrimary

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

NCT03000855Phase 2CompletedPrimary

EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures

NCT05233293Not ApplicableUnknown

Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma

NCT05804201Not ApplicableUnknownPrimary

EUS-guided Hepatico-gastrostomy With Hot Giobor

NCT04941924Not ApplicableUnknownPrimary

The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction.

NCT03812250Not ApplicableCompletedPrimary

EUS-guided Biliary Drainage vs. ERCP Assisted Transpapillary Drainage for Malignant Biliary Obstruction

Scroll to load more

Research Network

Activity Timeline